SCHEMBL23710025

SCHEMBL23710025

CCC1CN(F)CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21216997 0.75 — —
SCHEMBL7108405 0.74 — —
SCHEMBL20050549 0.74 — —
SCHEMBL18506891 0.72 DPP4 (0.40) —
SCHEMBL25530694 0.71 — —
SCHEMBL20976146 0.71 DRD2 (0.41) —
SCHEMBL21120635 0.71 DRD2 (0.41) —
SCHEMBL25530702 0.71 — —
SCHEMBL19808722 0.71 DRD2 (0.41) —
SCHEMBL25530700 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858832-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-08-04 — — EP disclosed
Send feedback